TheraKey™ is Compatible with any NGS Instrument
- TheraKey™ is compatible with any NGS instrument to provide accurate clinical information on somatic cancer mutations beyond the standard reporting
- We accept Variant Call Files (.vcf) from any Next-Generation Sequencing platforms and gene panel
- TheraKey™ saves up to 2 days of long database search, saving costs and accelerating turnaround time
TheraKey™ Delivers Accurate Patients-to-Treatments Matching at Scale
- TheraMiner: capable of seamless retrieval, parsing and filtering of data. Ingresses new clinical trials and updates on a daily basis from key public databases.
- TheraBase: Database (public + manually curated) of all clinical and genomic annotation information for gene, disease and treatment.
- TheraKey™ Interpretation Report: Clinical reports that contain information on Indicated Therapies, Contraindicated Therapies based on the patient’s unique genetic variants / mutations.
Vela Genomics Quality Knowledge Database
- 46 different biomedical databases such as COSMIC, UMLS, CIVIC, etc.
- Somatic mutations in 822 genes by Somatic Mutations Curated Content (SMCC)
- Draws data from >220,000 Clinical Trials
- Important prognostic germline mutations of raw content knowledge-base
Vela Genomics Highly Qualified Curators
Our in-house curators experts are certified clinicians (MBBS/MD) with PhD in Oncology. Leading practicing guidelines, recognized worldwide, are also used in curated report content review and feedback incorporation.
Indicated Therapies:
- FDA Approved Drugs List, Medical Journals
Contraindicated Therapies:
- NCCN Guidelines®
Clinical Trials:
- Clinical Parameters, Variants Detected
Continuous Update & Data Integration
Data is ever changing. In order to have the most accurate view, we must be able to efficiently capture that change, and react to it. With TheraKey™, physicians can be pro-actively advised on new therapeutic alternatives in an on-going fashion.
- TheraKey™ is powered by our data processing tool, TheraMiner, for seamless retrieval and parsing of data
- Authorizes updates of existing curated clinical trial data on a regular basis
- Continuous view of data growth – times of edits, attribution, nature of changes identified